|Podcasts|August 6, 2021
Repurposing Drugs for New Indications
Author(s)Catalent
In this podcast, Catalent Biologics regulatory expert, Kelly Davis shares her insights on why companies choose to repurpose drugs, what the main considerations are when doing so, how companies can overcome the challenges they face, and how Catalent supports companies going through this process.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
4
How Biopharma Navigates the 2026 Economic Shift
5